An islet cell transplant, performed at the University of Miami’s Diabetes Research Institute, is proving successful one year later. The islet cells, which produce insulin, were transplanted into a woman whose type 1 diabetes had been difficult for her to manage. Ideally, this research will help identify a suitable location within the body in which […]
A study says there may be another benefit to breastfeeding. Children who were breastfed had reduced risk of developing type 1 diabetes if they had been breastfed exclusively for at least six months, or partially breastfed for a year or more. Read more
Researchers believe they have found a way to “trick” the body into curing type 1 diabetes. While much testing remains to be done, they are hopeful this will have a great impact on the future for people with type 1 diabetes, and perhaps have potential to address type 2 as well. Read more
Type 1 diabetes requires constant vigilance. Patients with diabetes must track their blood sugar levels constantly, and calibrate insulin dosage accordingly; and even with constant management the risk of taking too much or too little insulin is always present. Can the field of synthetic biology — which incorporates computer science, engineering, and biology — offer the […]
A recent study has looked into whether Victoza and other drugs in its class (GLP-1 agonists) can help people with type 1 diabetes to lower their blood glucose levels and lower risk of diabetic ketoacidosis (DKA). The study, conducted by researchers at the Diabetes and Endocrinology Center of Western New York, investigated whether Victoza could reduce production […]
Diabetes researchers have long noticed that labs have different rates of success breeding mice to have the equivalent of Type 1 diabetes. At first, many scientists attributed this to poor management of genetic drift in some labs, but this theory didn’t hold up. If you transferred a group of mice from a lab with a […]
A recent update on diabetic retinopathy by American Diabetes Association (ADA) has considerably improved in terms of diagnosing and treating this complication since the 2002 ‘Position Statement.’ The statement was comprised of natural history of diabetic retinopathy with associated risk factors and different stages categorized by the growth of new blood vessels on the retina […]
For years, there has been a vocal minority of Type 1 diabetes activists who have claimed that a low-calorie, low-carb diet is a great, but often ignored, treatment option for maintaining blood glucose levels with Type 1 diabetes. Now, a new study may provide strong scientific evidence that such a diet-focused treatment restores beta cell […]
The proportion of deaths attributable to diabetes in the US is as high as 12 percent—three times higher than estimates based on death certificates suggest—a new analysis shows.
We’ve been listening to earnings calls and talking with company execs, industry insiders and PR teams to get a sense of what else is on the horizon, compiled in the following report.
Regular physical activity and exercise are recommended for the general population for overall improved health. However, exercise of moderate intensity increases the risk of hypoglycemia during and following exertion in those with type 1 diabetes mellitus (T1DM). Accordingly, exercise guidelines for T1DM focus on prevention of exercise-induced hypoglycemia.
A new Bluetooth insulin dose tracker, called Insulog, can be fitted onto most existing insulin pens to prevent dose errors in people with type 1 diabetes and insulin-treated type 2 diabetes. The device, created by a Tel Aviv-based startup, is the object of an online crowdfunding campaign recently launched on Indiegogo.
On World Diabetes Day, a consortium of international medical organizations is highlighting the fact that a quarter of people with diabetes are not discussing eye complications with their healthcare professional, despite a worldwide survey indicating that vision loss is feared twice as much as other common complications of diabetes.
With the surprising announcement this month that the FDA had cleared the way for Medtronic’s 670G hybrid system, sometimes referred to as an artificial pancreas, most people with diabetes were swinging their pump tubing with glee or juggling their (safety-capped) syringes in delight. And with good reason. We are on the cusp of a flood […]
Diabetic retinopathy is the most common vascular complication of diabetes, and the leading cause of vision loss among working age Americans. Experts estimate a half a billion eyes will be affected by diabetic retinopathy worldwide by the year 2030. Left untreated, it leads to blindness after 20 to 30 years with diabetes.
Over 42,000 people have signed the 2nd Annual More for a Cure petition, which has called for increased funding into type 1 diabetes research. The US petition, which was launched on 6 September 2016 by the Juvenile Diabetes Cure Alliance (JDCA), has already acquired twice as many signatures in six weeks than last year’s petition […]
Last month, a major scientific journal published an unprecedented three papers from the congress, including “New Insulin Delivery Recommendations” from the 183 doctors, nurses, educators, and conference attendees in Rome. The publications are based on results of what is probably the largest survey ever done concerning insulin injection technique in more than 13,000 insulin-injecting people […]
A novel treatment meant to stop Type 1 diabetes by increasing the number of T cells in the body is being given special attention by the FDA. The treatment, called CLBS03, has recently been granted Fast Track status by federal regulators, a designation which speeds up the approval process.
Unfortunately, researchers are finding that people with one autoimmune condition are prone to others. For example, a recent study has found that people with celiac disease and Type 1 diabetes have a higher risk of also developing autoimmune thyroid disease.
A new study on life expectancy and Type 1 diabetes has brought results that can be seen as glass half-empty or glass half-full. The bad news is that life expectancy for people with Type 1 is still shorter than that of the average population; the good news is that people with Type 1 are living […]